PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Symptom | |portal hypertension |
| Sentences | 72 |
| PubMedID- 23559324 | Olt was performed at the age of 7 years, due to liver cirrhosis with portal hypertension, in the absence of neurological lesions and an almost-normal brain mri. |
| PubMedID- 25543221 | liver cirrhosis with portal hypertension is also associated with the presence of pahs in 1-2% of cases. |
| PubMedID- 23729979 | Portal vein interventions in liver transplant recipients represent a group of interventions in the management of several disease entities including portal vein stenosis, portal vein thrombosis, and recurrent liver cirrhosis with portal hypertension with and without gastric varices. |
| PubMedID- 25798930 | Objective: to investigate the role of contrast-enhanced ultrasonography (ceus) and doppler ultrasonography (dus) in the diagnosis of severe portal hypertension (ph) in patients with liver cirrhosis (lc). |
| PubMedID- 20653965 | Patent paraumbilical and abdominal subcutaneous veins are found frequently as collaterals in patients due to portal hypertension, mainly associated with liver cirrhosis . |
| PubMedID- 23964340 | This is because duodenal varices are located deep in the serosal layer, while esophageal varices are located in the submucosal area.3 the most common cause (30%) of duodenal varices is portal hypertension due to liver cirrhosis. |
| PubMedID- 25120838 | One of the most prevalent non-neoplastic causes is portal hypertension mostly due to liver cirrhosis. |
| PubMedID- 26412302 | Additionally, neo-angiogenesis has been identified as a key mechanism in the progression of liver cirrhosis with portal hypertension3. |
| PubMedID- 24729881 | 17 (7%) patients had a mild hepatic comorbidity (score 1) (bilirubin > uln to 1.5 × uln or ast/alt > uln to 2.5 × uln) and 1 patient additional liver cirrhosis with portal hypertension (score 3). |
| PubMedID- 24563796 | Relevant diagnoses of the patient were (i) known hypertensive cardiac disease (transthoracic echocardiography 6 months before had shown a lv-ef of 54% and a light mitral and tricuspid insufficiency) and (ii) liver cirrhosis with portal hypertension. |
| PubMedID- 24697006 | In second pregnancy, medically induced abortion was performed in the 12th week because of deterioration of the underlying disease, liver cirrhosis with portal hypertension. |
| PubMedID- 22957328 | Liver elastography for the diagnosis of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 22878372 | This is due to the common practice of intermittent clamping of drains, because of a perceived risk of hypotension with free drainage, based on historical experience with paracentesis for transudative ascites due to hypo-albuminaemia and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 23909264 | Results: hepatic vein catheterisation is reliable for assessing the portal hypertension in the group of patients with liver cirrhosis of ethylic etiology. |
| PubMedID- 24757655 | Background/aims: this retrospective study assessed the clinical outcome of a transjugular intrahepatic portosystemic shunt (tips) procedure for managing portal hypertension in koreans with liver cirrhosis. |
| PubMedID- 21460144 | Methods: spectral doppler sonography of the hepatic vein was performed on 22 consecutive patients who underwent hvpg measurement for portal hypertension with liver cirrhosis. |
| PubMedID- 23247799 | 1endoscopic appearance of small bowel lesions related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 24339715 | Severe chronic illness included liver cirrhosis with portal hypertension, new york heart association class iv congestive heart failure, chronic respiratory disease, end-stage renal disease, or an immune-compromised state (e.g., leukemia, lymphoma, or aids). |
| PubMedID- 24400086 | The hemodynamic alteration of portal hypertension in patients with liver cirrhosis contributes to most of the clinical manifestations of the disease: gastrointestinal bleeding, hepatic encephalopathy, ascites and renal failure. |
| PubMedID- 24914368 | Selection of a tips stent for management of portal hypertension in liver cirrhosis: an evidence-based review. |
| PubMedID- 21705304 | A detailed interview and examination by occupational health and other medical specialists revealed that the patient had been suffering from wilson's disease from the age of 13, and had now developed hepatic manifestations (compensated liver cirrhosis with portal hypertension), neurological manifestations (dystonia, dysarthria, muscle weakness, vertigo), and psychiatric manifestations (depression, insomnia, cognitive impairment) of the disease, including problems partially caused by long-lasting treatment with copper chelating agents (neurological and haematological manifestations). |
| PubMedID- 23452051 | Functional variants of enos and inos genes have no relationship to the portal hypertension in patients with liver cirrhosis. |
Page: 1 2